FDA approved long-acting Antipsychotic Paliperidone Palmitate, the first 6 Monthly injectable for the treatment of schizophrenia.
Good News for patients of Schizophrenia! The Janssen Pharmaceutical Companies which is a part of Johnson & Johnson, have announced that the US Food and Drug Administration (FDA) approved the first-and-only six monthly injectable for the treatment of schizophrenia. The drug is atypical antipsychotic and is named as Invega Hayfera™ (paliperidone palmitate). “This is great …